Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins

Aims A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease (MND), although the pathological mechanism(s) underlying disease remains uncertain. Methods Using antibodies to poly‐GA, poly‐GP, poly‐GR,...

Full description

Saved in:
Bibliographic Details
Published inNeuropathology and applied neurobiology Vol. 42; no. 3; pp. 242 - 254
Main Authors Davidson, Y., Robinson, A. C., Liu, X., Wu, D., Troakes, C., Rollinson, S., Masuda-Suzukake, M., Suzuki, G., Nonaka, T., Shi, J., Tian, J., Hamdalla, H., Ealing, J., Richardson, A., Jones, M., Pickering-Brown, S., Snowden, J. S., Hasegawa, M., Mann, D. M. A.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.04.2016
Wiley Subscription Services, Inc
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aims A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease (MND), although the pathological mechanism(s) underlying disease remains uncertain. Methods Using antibodies to poly‐GA, poly‐GP, poly‐GR, poly‐AP and poly‐PR proteins, we examined sections of cerebral cortex, hippocampus, thalamus, cerebellum and spinal cord, from 20 patients with bvFTD and/or MND bearing an expansion in C9orf72 for aggregated deposits of dipeptide repeat proteins (DPR). Results Antibodies to poly‐GA, poly‐GP and poly‐GR detected numerous rounded cytoplasmic inclusions (NCI) within granule cells of hippocampal dentate gyrus and those of the cerebellum, as well as ‘star‐burst’ shaped NCI in pyramidal neurones of CA3/4 region of hippocampus. NCI were uncommon in Purkinje cells, and only very rarely seen in anterior horn cells. Poly‐PA antibody detected occasional NCI within CA3/4 neurones alone, whereas poly‐PR antibody did not identify any NCI but immunostained the nucleus of anterior horn cells, CA3/4 neurones and Purkinje cells, in patients with or without expansion in C9orf72, as well as in normal controls. Poly‐GA antibody generally detected more DPR than poly‐GP, which in turn was greater than poly‐GR. All patients with bvFTD + MND or MND showed plentiful p62/TDP‐43 positive inclusions in remaining anterior horn cells. Conclusion Degeneration and loss of anterior horn cells associated with expansions in C9orf72 occurs in the absence of DPR, and implies that changes involving loss of nuclear staining for and a cytoplasmic aggregation of TDP‐43 are more likely to be the cause of this. Abundant dipeptide repeat aggregates in regions without neurodegeneration and the sparsity of inclusions in lower motor neurons in cases with motor neuron disease support the conclusion that dipeptide repeat pathology is not the direct cause of neurodegeneration.
Bibliography:Wellcome Trust - No. 089701/Z/09/Z
Medical Research Council
istex:47FFFEE8E116AB8BA073BB09E23E43E7CE32BA49
ark:/67375/WNG-Q3Z3KPWN-9
Alzheimer's Society
Figure S1. Specificity of antibodies for their antigenic protein as determined by ELISA, for anti GR (A), anti GP (B) anti AP and anti PR (both C) antibodies.Figure S2. Specificity of antibodies for their antigenic protein as determined by Western blotting of proteins extracted from cell lines expressing the relevant peptide.Table S1. selected clinical, neuropathological and genetic data on the 29 cases employed in the study.Table S2. Post hoc (Mann-Whitney) significance values for comparisons between scores for DPR immunostaining using antibodies against poly-GA, poly-GP and poly-GR proteins following attainment of significant difference when comparing scores for all three antibodies by Kruskal-Wallis test. Table S3. Significance values for comparisons of scores (by Mann-Whitney test) for DPR immunostaining in different brain regions using Manchester and Tokyo poly-GP, and Manchester and Tokyo poly-GR antibodies.
Institutions of Higher Education for Academic Disciplinary Innovations - No. B08006
Alzheimer's Research UK
ArticleID:NAN12292
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The copyright line for this article was changed on March 30, 2016 after original online publication.
ISSN:0305-1846
1365-2990
DOI:10.1111/nan.12292